Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children

Pediatric Dermatology

Volumn 14, Issue 4, 1997, Pages 321-324

  Lucky, Anne W ^a   Leach, Alan D ^b   Laskarzewski, Peter ^b   Wenck, Horst ^c  

^a Dermatology Research Associates   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c BEIERSDORF AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; LANOLIN ALCOHOL;

ADJUVANT THERAPY; ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030795104     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.1997.tb00968.x     Document Type: Article

References (17)

1. Lapidus CX, Schwarz DF, Honig PJ. Atopic dermatitis in children: Who cares? Who pays? J Am Acad Dermatol 1993;28:699-703.
2. Drake LA, Ceilley RI, Cornelison RL, Dobes A, Dorner W, Goltz RW, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol 1992;26:485-488.
3. Sampson HA. Atopic dermatitis. Ann Allerg 1992;69:469-477.
4. Queille-Roussel C, Raynaud F, Saurat J-H. A prospective computerized study of 500 cases of atopic dermatitis in childhood. Acta Dermatol Venereol (Stockh) 1985; 114(suppl):87-92.
5. Hanifin JM. Atopic dermatitis in infants and children. Pediatr Clin North Am 1991;38:763-788.
6. Korting HC, Kerscher MJ, Schafer-Korting M. Topical glucocorticoids with improved benefit/risk ratio: do they exist? J Am Acad Dermatol 1992;27:87-92.
7. Hanifin JM. Atopic dermatitis: New therapeutic considerations. J Am Acad Dermatol 1991;24:1097-1101.
8. Lesnik RH, Mezick JA, Capetola R, Kligman LH. Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect. J Am Acad Dermatol 1989;21:186-190.
9. De Prost Y. Atopic dermatitis: Recent therapeutic advances. Pediatr Dermatol 1992;9:386-389.
10. Watsky KL, Freije L, Leneveu M-C, Wenck HA, Leffell DJ. Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis 1992;50:383-386.
11. Akers WA. Risks of unoccluded topical steroids in clinical trials. Arch Dermatol 1980;116:786-788.
12. Munro DD. The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in patients. Br J Dermatol 1976;94(suppl 12):67-76.
13. Burden AD, Beck MH. Contact hypersensitivity to topical corticosteroids. Br J Dermatol 1992;127:497-500.
14. Feinblatt BI, Aceto T Jr, Beckhorn G, Bruck E. Percutaneous absorption of hydrocortisone in children. Am J Dis Child 1966;112:218-224.
15. Curtis JA, Cromode E, Laski B, Toole J, Howard N. Endocrine complications of topical and intralesional corticosteroid therapy. Arch Dis Child 1982;57:204-207.
16. Ruiz-Maldonado R, Zapata G, Tamayo L, Robles C. Cushing's syndrome after topical application of corticosteroids. Am J Dis Child 1982;136:274-275.
17. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C. Potential hazards of topical steroid therapy. Am J Dis Child 1983;137:1130-1131.